Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Jaguar Health, Inc. | jagx-20191231x10k.htm |
| EX-32.2 - EX-32.2 - Jaguar Health, Inc. | jagx-20191231ex322bc710d.htm |
| EX-32.1 - EX-32.1 - Jaguar Health, Inc. | jagx-20191231ex3212c9236.htm |
| EX-31.2 - EX-31.2 - Jaguar Health, Inc. | jagx-20191231ex3120cb334.htm |
| EX-31.1 - EX-31.1 - Jaguar Health, Inc. | jagx-20191231ex311163973.htm |
| EX-23.2 - EX-23.2 - Jaguar Health, Inc. | jagx-20191231ex232e7a3ed.htm |
| EX-10.101 - EX-10.101 - Jaguar Health, Inc. | jagx-20191231ex10101a436.htm |
| EX-4.26 - EX-4.26 - Jaguar Health, Inc. | jagx-20191231ex426e78444.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Jaguar Health, Inc.
San Francisco, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (Nos. 333-214956 and 333-227292), Form S-3 (Nos. 333-220236 333-221041 and 333-224387) and Form S-8 (Nos. 333-204280, 333-215303, 333-219939 and 333-225057) of Jaguar Health, Inc. of our report dated April 10, 2019, relating to the consolidated financial statements which appear in this Form 10-K. Our report contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
/s/ BDO USA, LLP
San Francisco, California
April 2, 2020